The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy
Ahmad, Shamaila Munir, Martinenaite, Evelina, Holmström, Morten, Jørgensen, Mia Aaboe, Met, Özcan, Nastasi, Claudia, Klausen, Uffe, Donia, Marco, Pedersen, Lars Møller, Munksgaard, Lars, Ødum, Niels,Language:
english
Journal:
OncoImmunology
DOI:
10.1080/2162402X.2017.1390641
Date:
October, 2017
File:
PDF, 3.33 MB
english, 2017